Sanner Group, a leading CDMO (Contract Development and Manufacturing Organization), is ramping up its services for medical devices, reinforcing its position as a key player in the medtech industry. With a focus on customer-specific needs, Sanner offers full-service solutions for the development and production of drug delivery devices, diagnostic equipment, and other medtech products. The company’s advanced prototyping capabilities enable efficient and low-risk pilot projects, industrialization, and scale-up planning, making it a valuable partner from start to finish.
Global Expansion of Manufacturing Facilities
In November 2024, Sanner Group’s new production facility and global headquarters in Bensheim, Germany, will become operational, with the complete transfer of production operations by mid-2025. The company has also recently opened a second facility in Kunshan, China, and is on track to establish a new site in the U.S. by 2025. These expansions will significantly increase Sanner’s capacity to handle small-series production, pilot runs, clinical batches, and full-scale manufacturing on a global scale.
Tailored Solutions for Medical Devices
Before transitioning to serial production, Sanner supports its customers with a rigorous approval process that includes smaller production quantities for engineering builds, stability testing, and clinical batches. Sanner’s mold design experts and automation engineers ensure a smooth progression from pilot to serial production. With special-purpose machines, robotic cells for partial automation, and FDA/GMP-compliant clinical batch production, the company ensures high efficiency. Additionally, Sanner’s class 7 and class 8 cleanrooms uphold the strictest quality and compliance standards throughout the manufacturing process.